Fingerprint
Dive into the research topics where Julio Wainstein is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Glycaemic, appetite and circadian benefits of a dairy-enriched diet with high-protein breakfast and early daytime-restricted carbohydrate intake in type 2 diabetes: a randomised crossover trial
Tsameret, S., Froy, O., Matz, Y., Landau, Z., Twito, O., Wainstein, J., Avital-Cohen, N., Chapnik, N. & Jakubowicz, D., Apr 2026, In: Diabetologia. 69, 4, p. 1021-1034 14 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Kidney and Survival Outcomes with Semaglutide by CKD Severity in the FLOW Trial
Tuttle, K. R., Mann, J. F. E., Mayrdorfer, M. M., Rayner, B., Pugliese, G., Pratley, R. E., Perkovic, V., Mahaffey, K. W., Kashihara, N., Jeppesen, O. K., Gumprecht, J., Correa-Rotter, R., Cherney, D. Z. I., Bosch-Traberg, H., Arici, M., Rossing, P., Porto, A., Oviedo, A., Elbert, A. & Gelersztein, E. & 385 others, , 2026, In: Clinical Journal of the American Society of Nephrology. Publish Ahead of PrintResearch output: Contribution to journal › Article › peer-review
Open Access -
Baseline Kidney Function, Albuminuria, and Urine Albumin-Creatinine Ratio Reduction with Finerenone, Empagliflozin, or Both
Mottl, A., Scott, C., Green, J. B., Heerspink, H. J. L., Mann, J. F. E., McGill, J. B., Nangaku, M., Rosenstock, J., Rossing, P., Li, L., Li, N., Vaduganathan, M., Agarwal, R., Nollet, A., Van Vlem, B., Duyck, F., Speeckaert, M., Doubel, P., Gillard, P. & Sahyouni, E. & 157 others, , 2025, In: Journal of the American Society of Nephrology. p. 1-13 13 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Combination effect of FInerenone and EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint (CONFIDENCE) trial: Baseline clinical characteristics
Agarwal, R., Green, J. B., Heerspink, H. J. L., Mann, J. F. E., McGill, J. B., Mottl, A. K., Rosenstock, J., Rossing, P., Vaduganathan, M., Brinker, M., Edfors, R., Li, N., Scheerer, M. F., Scott, C., Nangaku, M., Consoli, A., Awad, A., Arduan, A. O., Soto, A. & Iranmanesh, A. & 158 others, , 1 Aug 2025, In: Nephrology Dialysis Transplantation. 40, 8, p. 1559-1569 11 p.Research output: Contribution to journal › Article › peer-review
Open Access14 Scopus citations -
Autosomal Dominant, Long-Standing Dysglycemia in 2 Families with Unique Phenotypic Features
Hanukoglu, A., Banne, E., Lev, D. & Wainstein, J., 1 Jan 2024, In: Clinical Medicine Insights: Endocrinology and Diabetes. 17Research output: Contribution to journal › Article › peer-review
Open Access